Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?
Authors:
- R.J. BaylyRBR.J. Bayly
- V.J. LewingtonVLV.J. Lewington
- 1 January 1992
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 4 (2) , 101-107
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Strontium-89 chloride for pain palliation in prostatic skeletal malignancyBritish Journal of Radiology, 1991
- Phosphorus-32 for intractable bony pain from carcinoma of the prostateClinical Oncology, 1990
- Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patientsClinical Oncology, 1989
- Sr-89 therapy for metastatic bone disease: scintigraphic and radiographic follow-up.Radiology, 1987
- Adrenal androgen blockade in relapsed prostate cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Cancer of the Prostate. Do Younger Men have a Poorer Survival Rate?British Journal of Urology, 1984
- The Prognosis of Prostatic Cancer in the Younger ManBritish Journal of Urology, 1983
- Half‐body Irradiation in the Treatment of Metastatic Prostatic CarcinomaBritish Journal of Urology, 1981
- Half body radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1976
- Current Status of Bilateral Adrenalectomy or Advanced Prostatic CarcinomaAnnals of Surgery, 1974